Market Snapshot

High-signal KPIs designed for executive scanning.

Indicative snapshot. Request sample for full model outputs.

Market Size (latest)

—

— vs. prior year

CAGR

—

Forecast window: —

Forecast Period

2024–2031

Base years: 2019–2023

Coverage Depth

—

Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

Market Overview:

The global melanoma treatment market encompasses therapies targeting malignant melanoma, the most aggressive form of skin cancer. Driven by rising UV exposure, genetic predisposition, and improved diagnostic technologies, the market is shifting toward immunotherapies (PD-1/CTLA-4 inhibitors), targeted therapies (BRAF/MEK inhibitors), and AI-driven early detection tools. North America and Europe dominate due to high awareness and reimbursement policies, while Asia-Pacific shows rapid growth with increasing healthcare investments.

Market Size and Forecast

Year	Market Value (USD Billion)	Notes
2023	5.2	Immunotherapies account for 55% revenue.
2028	8.6	CAGR 10.5% (2023–2028): BRAF/MEK combos gain traction.
2035	12.4	CAGR 9.8% (2028–2035): mRNA vaccines and AI diagnostics scale.

By 2035, over 500,000 patients annually will receive advanced therapies, with immunotherapy adoption expected to double in emerging markets.

Market Drivers

Immunotherapy breakthroughs: PD-1 inhibitors (Keytruda, Opdivo) improve five-year survival to 40% (vs. 15% pre-2015).
Precision medicine: Biomarker testing (BRAF, NRAS) informs 70% of treatment decisions in the U.S. and EU.
AI diagnostics: Tools like DermEngine decrease late-stage diagnoses by 25%.
Government initiatives: NIH and EU Horizon fund over 120 clinical trials for metastatic melanoma.

Market Challenges

High costs: Immunotherapy averages USD 150,000 per year, limiting access in LMICs.
Side effects: 30% of patients stop using CTLA-4 inhibitors because of toxicity.
Regulatory delays: The Asia-Pacific region lags in approvals (e.g., China’s NMPA takes over 3 years compared to the FDA’s 12 months). Competitive Landscape

Company	2023 Share	Core Strengths	Recent Moves
Merck & Co.	35%	Keytruda (PD-1 inhibitor)	Expanded adjuvant use to Stage IIB (2024).
Bristol-Myers Squibb	28%	Opdivo + Yervoy combo	Phase III trials for ocular melanoma (2025).
Novartis	15%	Tafinlar + Mekinist (BRAF/MEK)	Launched liquid biopsy companion test (2024).
Startups (e.g., NeraCare)	22%	AI staging tools	Raised USD 300M for hyperspectral imaging (2025).

Market Segmentation

Segment	2023 Share	CAGR (2023–2035)
By Therapy
Immunotherapy	55%	11.2%
Targeted Therapy	30%	9.5%
By Stage
Stage III–IV	XX%	10.8%
Stage 0–II (adjuvant)	XX%	13.1%

Regional Analysis

North America (48%): The U.S. has 90% insurance coverage for immunotherapies.
Europe (XX%): Germany’s universal biomarker testing fuels 15% annual growth.
Asia-Pacific (XX%): Japan accelerates novel therapies (e.g., Delcath’s CHEMOSAT).

Technology & Innovation

mRNA vaccines: Moderna/BioNTech’s personalized melanoma vaccine (Phase III, 2025).
Liquid biopsies: Guardant360 CDx gains FDA approval for resistance monitoring (2024).
AI-pathology: Paige.AI’s algorithm detects micro-metastases with 95% accuracy.

Regulatory Environment

FDA: Accelerated approvals for TIL therapies (e.g., Iovance’s Lifileucel).
EMA mandates companion diagnostics for BRAF inhibitors.
China's NMPA prioritizes domestic PD-1 inhibitors, such as Toripalimab.

Strategic Outlook

Hospitals: Must invest in biomarker testing infrastructure.
Pharma: Focus on combo therapies to overcome resistance.
Payers: Expand reimbursement for early-stage adjuvant treatments.

Unlock the executive summary.

Request the sample to review key questions answered.

See what’s included.

Request sample for scope, definitions and segmentation.

Key Players

Hoffmann‑La Roche Ltd
Bristol‑Myers Squibb
Novartis AG
Genentech Inc.
AstraZeneca plc
Sanofi S.A.
Amgen Inc.
Takeda Pharmaceutical Company
Merck & Co Inc.
Pfizer Inc.
GlaxoSmithKline plc
Eli Lilly and Company
Regeneron Pharmaceuticals Inc.
Moderna Inc.
Iovance Biotherapeutics Inc.

Competitive Dashboard Preview

Shortlist strategic accounts and benchmark positioning.

Loading…

Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.

Refine View

Geography Segment Sub-segment

—

Request A Custom Cut

Opportunity Index

Directional signals for prioritization and scenario framing.

Interactive

Need a board-ready slide? .

Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Melanoma Treatment Market Report

1. Melanoma Treatment Market Research Report
1. 1.1 Study Objectives
2. 1.2 Melanoma Treatment Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Melanoma Treatment Market Research Report - Preface
1. 2.1 Melanoma Treatment Market Research Report – Detailed Scope and Definitions
  1. 2.1.1 By Therapy
  2. 2.1.2 By Stage
  3. 2.1.3 By Region
3. Melanoma Treatment Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Therapy, By Stage, By Country
3. 3.3. Opportunities – By Therapy, By Stage, By Country
4. 3.4. Trends – By Therapy, By Stage, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Melanoma Treatment Market Research Report – DROTs Impact Analysis

1. 4. Melanoma Treatment Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031

5. Melanoma Treatment Market, By Therapy, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Immunotherapy
2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 5.2 Targeted Therapy
7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Melanoma Treatment Market, By Stage, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Stage III–IV
2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. 6.2 Stage 0–II (adjuvant)
7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031

7. Melanoma Treatment Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 North America
  1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  7.2 Europe
  1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  7.3 Asia-Pacific
  1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  7.4 Latin America
  1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  7.5 Middle East and Africa
  1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
  2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
  3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
  4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  7.6 Melanoma Treatment Market - Opportunity Analysis Index, By Therapy, By Stage, and Region, 2024 - 2031

8. North America Melanoma Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 By Therapy Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 8.1.1 Immunotherapy
  2. 8.1.2 Targeted Therapy
  8.2 By Stage Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 8.2.1 Stage III–IV
  2. 8.2.2 Stage 0–II (adjuvant)
  8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 8.3.1 United States
  2. 8.3.2 Canada
2. 8.4 North America Melanoma Treatment Market – Opportunity Analysis Index, By Therapy, By Stage, and Country, 2024 - 2031
3. 8.5 Regional Trends Analysis
4. 8.6 North America Melanoma Treatment Market Research Report - Company Profiles
  1. 8.6.1 Company 1 (United States)
  2. 8.6.2 Company 2 (Canada)
  3. 8.6.3 Company 3 (Canada)
9. Europe Melanoma Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 9.1 By Therapy Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.1.1 Immunotherapy
  2. 9.1.2 Targeted Therapy
  9.2 By Stage Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.2.1 Stage III–IV
  2. 9.2.2 Stage 0–II (adjuvant)
  9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 9.3.1 Germany
  2. 9.3.2 United Kingdom
  3. 9.3.3 France
  4. 9.3.4 Spain
  5. 9.3.5 Italy
  6. 9.3.6 Russia
2. 9.4 Europe Melanoma Treatment Market – Opportunity Analysis Index, By Therapy, By Stage, and Country, 2024 - 2031
3. 9.5 Regional Trends Analysis
4. 9.6 Europe Melanoma Treatment Market Research Report - Company Profiles
  1. 9.6.1 Company 1 (Germany)
  2. 9.6.2 Company 2 (United Kingdom)
  3. 9.6.3 Company 3 (United Kingdom)
10. Asia-Pacific Melanoma Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 10.1 By Therapy Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.1.1 Immunotherapy
  2. 10.1.2 Targeted Therapy
  10.2 By Stage Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.2.1 Stage III–IV
  2. 10.2.2 Stage 0–II (adjuvant)
  10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 10.3.1 China
  2. 10.3.2 Japan
  3. 10.3.3 India
  4. 10.3.4 South Korea
  5. 10.3.5 Australia & New Zealand
  6. 10.3.6 ASEAN
2. 10.4 Asia-Pacific Melanoma Treatment Market – Opportunity Analysis Index, By Therapy, By Stage, and Country, 2024 - 2031
3. 10.5 Regional Trends Analysis
4. 10.6 Asia-Pacific Melanoma Treatment Market Research Report - Company Profiles
  1. 10.6.1 Company 1 (China)
  2. 10.6.2 Company 2 (Japan)
  3. 10.6.3 Company 3 (Japan)
11. Latin America Melanoma Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 11.1 By Therapy Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.1.1 Immunotherapy
  2. 11.1.2 Targeted Therapy
  11.2 By Stage Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.2.1 Stage III–IV
  2. 11.2.2 Stage 0–II (adjuvant)
  11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 11.3.1 Brazil
  2. 11.3.2 Mexico
  3. 11.3.3 Argentina
  4. 11.3.4 Peru
  5. 11.3.5 Colombia
  6. 11.3.6 Rest of Latin America
2. 11.4 Latin America Melanoma Treatment Market – Opportunity Analysis Index, By Therapy, By Stage, and Country, 2024 - 2031
3. 11.5 Regional Trends Analysis
4. 11.6 Latin America Melanoma Treatment Market Research Report - Company Profiles
  1. 11.6.1 Company 1 (Brazil)
  2. 11.6.2 Company 2 (Mexico)
  3. 11.6.3 Company 3 (Mexico)
12. Middle East and Africa Melanoma Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 12.1 By Therapy Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.1.1 Immunotherapy
  2. 12.1.2 Targeted Therapy
  12.2 By Stage Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.2.1 Stage III–IV
  2. 12.2.2 Stage 0–II (adjuvant)
  12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
  1. 12.3.1 Saudi Arabia
  2. 12.3.2 UAE
  3. 12.3.3 South Africa
  4. 12.3.4 Egypt
  5. 12.3.5 Israel
  6. 12.3.6 Rest of Middle East and Africa
2. 12.4 Middle East and Africa Melanoma Treatment Market – Opportunity Analysis Index, By Therapy, By Stage, and Country, 2024 - 2031
3. 12.5 Regional Trends Analysis
4. 12.6 Middle East and Africa Melanoma Treatment Market Research Report - Company Profiles
  1. 12.6.1 Company 1 (Saudi Arabia)
  2. 12.6.2 Company 2 (UAE)
  3. 12.6.3 Company 3 (UAE)
13. Competition Landscape
1. 13.1 Strategic Dashboard of Top Market Players
2. 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
  1. 13.2.1 Bristol‑Myers Squibb
  2. 13.2.2 Merck & Co.
  3. 13.2.3 Novartis AG
  4. 13.2.4 F. Hoffmann‑La Roche Ltd.
  5. 13.2.5 AstraZeneca
  6. 13.2.6 Amgen Inc.
  7. 13.2.7 Pfizer Inc.
  8. 13.2.8 Sanofi S.A.
  9. 13.2.9 Takeda Pharmaceutical Company
  10. 13.2.10 Johnson & Johnson
  11. 13.2.11 Bayer AG
  12. 13.2.12 GlaxoSmithKline plc
  13. 13.2.13 Iovance Biotherapeutics Inc.
  14. 13.2.14 Polynoma LLC
  15. 13.2.15 Moderna

14. Data Collection Method and Research Approach
15. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.

Triangulated Sizing

Bottom-up, top-down, and peer benchmarks reconciled by analysts.

Primary + Secondary Research

Executive interviews combined with validated public and paid sources.

Scenario & Sensitivity

Base, bull and bear cases to stress-test strategic moves.

Book A Consultation

Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.

Global Advanced Musculoskeletal Care Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30116 Dec. 1, 2025

$3600.00 single user

View report →

Global Under-Arm Exoskeletons Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI0112 Dec. 1, 2025

$3600.00 single user

View report →

Global LED Lip Masks Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30115 Dec. 1, 2025

$3600.00 single user

View report →

Global Light-Powered Joint Support Systems Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30114 Nov. 30, 2025

$3600.00 single user

View report →

Global Dual Microcurrent Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30113 Nov. 30, 2025

$3600.00 single user

View report →

Global Wearable Medical-Grade Cold Lasers Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI3011 Nov. 30, 2025

$3600.00 single user

View report →

Global Wearable Light Therapy Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI30112 Nov. 30, 2025

$3600.00 single user

View report →

Global Targeted Air Compression Therapies Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2711 Nov. 27, 2025

$3600.00 single user

View report →

Global Wearable Light-Emitting Diodes (LEDs) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI27111 Nov. 27, 2025

$3600.00 single user

View report →

Global Robotic Hand Assistance Solutions Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI2611 Nov. 26, 2025

$3600.00 single user

View report →

Istanbul Hair Transplant Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI26081 Aug. 26, 2025

$3600.00 single user

View report →

Global Osteo-Odonto-Keratoprosthesis (OOKP) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

CVMI1008 Aug. 10, 2025

$3600.00 single user

View report →

Ready to move from data to decision?

Get the report, request a sample, or book a consultative briefing.

Buy Report Talk To An Analyst

Global Melanoma Treatment Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

Market Snapshot

Insights

Key Players

Segmentation Explorer

Table Of Contents

Melanoma Treatment Market Report

Methodology & Credibility

Related Reports